Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06474364 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06474364 · ClinicalTrials.gov record · last posted 2025-07-29

HIV Prevention and Care Interventions for Youth in Uganda

Study acronym: HIPCY
StatusRecruiting
PhasePhase 4
Started2024-08-05
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
Several studies show that Adolescents and Young Adults (AYA) have poor outcomes along the entire Human Immunodeficiency Virus (HIV) prevention and care cascades compared to adults. The investigators propose to evaluate novel evidence-based HIV prevention and care interventions (including Cabotegravir LongActing (CABLA) to determine implementation outcomes among AYA who are at particularly high risk for HIV acquisition and poor viral suppression in five geographically distinct research performance sites in Uganda. The results will provide important evidence to inform Uganda and other regional countries' policy on integrated HIV prevention, care and treatment for AYA at high risk for HIV and Sexually Transmitted Infections (STIs) in order to reach the UNAIDS 95-95-95 targets and HIV epidemic control.

Amendment record 1 amendment on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended once since 2024-06-19. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2025-07-25
Status change Not Yet Recruiting→Recruitingv1
Trial Details
NCT Number NCT06474364
Lead Sponsor MU-JHU CARE
Collaborators: Makerere University Joint AIDS Program, Infectious Diseases Research Collaboration, Uganda, Baylor College of Medicine, University of California, San Francisco
Conditions HIV
Enrollment 600 participants
Start Date 2024-08-05
Primary Completion 2028-08-31 (estimated)
Study Completion 2028-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-29